VISION aims to provide validated regulatory modules, quantitative models for gene regulation, and guides for translating research from mouse models to human.
The prototype system uses viral genome data to act as a framework for real-time molecular epidemiology and evolutionary analysis of emerging epidemics.
The centers are using the standardized pipeline to help streamline data sharing and data analysis to achieve their larger research goals.
GenePeeks will provide its Virtual Progeny Analytics approach, which includes scores that predict gene function and associated disease risk in hypothetical babies.
The system allows oncologists to pick treatment regimens using NantHealth's decision support tool, and order them directly through Allscript's EHR system.
Congenica will use the proceeds to establish its presence in the US and China, where it will court not only clinical genetics labs, but specialists, academics, biotech, and pharma.
The company will use the proceeds from the round to invest in sales and marketing efforts for its Sapientia clinical genome analysis platform, as well as for R&D.
The service will be incorporated into the Washington-based healthcare system's EHR system in order to advance its precision medicine efforts.
The firm is counting on its experience integrating data from the oil and gas industry to change the way pharmaceutical data scientists work.
Santen Inc., the US subsidiary of Japanese firm Santen Pharmaceuticals, will have exclusive rights to drug candidates discovered by twoXARs algorithms.
Two research groups reported on statistical methods for uncovering methylated cytosine and/or adenine bases using electrical current cues from Oxford Nanopore sequencers.
Researchers used the approach, which analyzes somatic copy number alterations, to identify a targetable pathway, which they then blocked effectively using currently available drugs.
The dbGaP was launched in late 2006 to house genotypic and phenotypic data from large-scale genome-wide association studies.
Researchers from the cancer center recently published reverse-phase protein array-based characterizations covering more than 700 cancer cell lines.
The activity follows a recent financing round that has enabled OncoDNA to build out its sales team as it courts new clients.
WuXi NextCode will integrate Geneformics' compression technology into its workflows to provide rapid, easy access to genomic datasets.
The deal brings together two firms to create new "drug knowledge" to inject pharmacogenomics into clinical workflows.
Researchers compared three open source annotation tools, and also looked at correspondence with public databases, identifying a number of stumbling blocks.
OncoDNA has launched two new precision cancer medicine projects, the budgets for which total €16 million and are being supported in part by the Belgian Walloon Region.
The company offers what it calls an "end-to-end solution" for assembling study cohorts, tackling a challenging part of the diagnostic development process.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.